Abbott: Influenza, Human trials
The registry lists 19 Influenza, Human studies with Abbott as lead sponsor. 1 are open to participants now and 1 have results posted.
Phase 1 1Phase 2 2Phase 3 9No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern HemisphereNot yet recruitingNCT06928129Not applicable
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 SeasonCompletedNCT02381418Phase 3Results posted
- Clinical Evaluation of the Panbio™ COVID-19/Flu A&B PanelCompletedNCT06127108Not applicable
- Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home UseCompletedNCT06124638Not applicable
- Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Device and the Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test DeviceCompletedNCT05715515Not applicable
- Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Product Using Mid-Turbinate Nasal SwabsCompletedNCT05630365Not applicable
- Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel.CompletedNCT05354115Not applicable
- Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid PanelCompletedNCT05163730Not applicable
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 SeasonCompletedNCT01633749Phase 3
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2010/2011 SeasonCompletedNCT01146015Phase 3
- Immunogenicity and Safety of a Cell-derived Influenza Vaccine in ElderlyCompletedNCT01013675Phase 2
- Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived Influenza VaccineCompletedNCT00999206Phase 3
- Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus RevaccinationCompletedNCT00889889Phase 2
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 SeasonCompletedNCT00881842Phase 3
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.CompletedNCT00665509Phase 3
- Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 YearsCompletedNCT00599443Phase 1
- Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in EuropeCompletedNCT00479921Phase 3
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine for the 2006/2007 Influenza Season in Europe.CompletedNCT00346723Phase 3
- Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the 2006/2007 Influenza Season in Europe.WithdrawnNCT00345462Phase 3